0.09
Impact Factor
0.09
5-Years IF
10
5-Years H index
CitEc is a RePEc service
providing citation data for Economics since 2001
providing citation data for Economics since 2001
Last updated December, 3 2015 760.408 documents
processed, 20.499.313 references and 8.066.571 citations
[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [
trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
| IF | AIF | IF5 | DOC | CDO | CCU | CIF | CIT | D2Y | C2Y | D5Y | C5Y | %SC | CiY | II | AII | |
| 1990 | 0.09 | 0 | 0 | 0 | (%) | 0.03 | ||||||||||
| 1991 | 0.09 | 0 | 0 | 0 | (%) | 0.04 | ||||||||||
| 1992 | 0.09 | 0 | 0 | 0 | (%) | 0.04 | ||||||||||
| 1993 | 0.1 | 0 | 0 | 0 | (%) | 0.05 | ||||||||||
| 1994 | 0.11 | 0 | 0 | 0 | (%) | 0.05 | ||||||||||
| 1995 | 0.19 | 0 | 0 | 0 | (%) | 0.07 | ||||||||||
| 1996 | 0.23 | 0 | 0 | 0 | (%) | 0.09 | ||||||||||
| 1997 | 0.27 | 0 | 0 | 0 | (%) | 0.09 | ||||||||||
| 1998 | 0.27 | 125 | 125 | 55 | 0 | 0 | (%) | 0.1 | ||||||||
| 1999 | 0.31 | 106 | 231 | 7 | 0.03 | 39 | 125 | 125 | (%) | 1 | 0.01 | 0.13 | ||||
| 2000 | 0.03 | 0.39 | 0.03 | 100 | 331 | 7 | 0.02 | 47 | 231 | 6 | 231 | 6 | (%) | 1 | 0.01 | 0.15 |
| 2001 | 0.02 | 0.41 | 0.02 | 90 | 421 | 8 | 0.02 | 37 | 206 | 5 | 331 | 7 | (%) | 0.16 | ||
| 2002 | 0.01 | 0.43 | 0.01 | 83 | 504 | 3 | 0.01 | 34 | 190 | 2 | 421 | 3 | (%) | 0.19 | ||
| 2003 | 0.02 | 0.45 | 0.03 | 90 | 594 | 16 | 0.03 | 33 | 173 | 3 | 504 | 13 | (%) | 0.19 | ||
| 2004 | 0.02 | 0.51 | 0.02 | 96 | 690 | 30 | 0.04 | 457 | 173 | 3 | 469 | 9 | (%) | 17 | 0.18 | 0.21 |
| 2005 | 0.31 | 0.54 | 0.14 | 107 | 797 | 73 | 0.09 | 48 | 186 | 57 | 459 | 64 | (%) | 2 | 0.02 | 0.22 |
| 2006 | 0.21 | 0.52 | 0.12 | 115 | 912 | 72 | 0.08 | 79 | 203 | 42 | 466 | 54 | (%) | 1 | 0.01 | 0.21 |
| 2007 | 0.05 | 0.45 | 0.14 | 86 | 998 | 76 | 0.08 | 20 | 222 | 10 | 491 | 67 | (%) | 0.18 | ||
| 2008 | 0.03 | 0.48 | 0.14 | 86 | 1084 | 79 | 0.07 | 69 | 201 | 7 | 494 | 68 | (%) | 1 | 0.01 | 0.2 |
| 2009 | 0.03 | 0.48 | 0.13 | 88 | 1172 | 82 | 0.07 | 39 | 172 | 6 | 490 | 66 | (%) | 0.19 | ||
| 2010 | 0.06 | 0.44 | 0.06 | 108 | 1280 | 94 | 0.07 | 69 | 174 | 11 | 482 | 28 | (%) | 0.16 | ||
| 2011 | 0.08 | 0.53 | 0.08 | 86 | 1366 | 98 | 0.07 | 32 | 196 | 15 | 483 | 40 | (%) | 2 | 0.02 | 0.21 |
| 2012 | 0.17 | 0.58 | 0.11 | 94 | 1460 | 150 | 0.1 | 39 | 194 | 33 | 454 | 48 | (%) | 7 | 0.07 | 0.22 |
| 2013 | 0.14 | 0.71 | 0.11 | 1460 | 126 | 0.09 | 180 | 25 | 462 | 53 | (%) | 0.25 | ||||
| 2014 | 0.09 | 0.81 | 0.09 | 1460 | 130 | 0.09 | 94 | 8 | 376 | 32 | (%) | 0.28 |
| IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y IF5: Impact Factor: C5Y / D5Y DOC: Number of documents published in year y CDO: Cumulative number of documents published until year y CCU: Cumulative number of citations to papers published until year y CIF: Cumulative impact factor CIT: Number of citations to papers published in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 D5Y: Number of articles published in y-1 until y-5 C5Y: Cites in y to articles published in y-1 until y-5 %SC: Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y II: Immediacy Index: CiY / Documents. AII: Average Immediacy Index for series in RePEc in year y |
|
50 most cited documents in this series:
[Click on heading to sort table]
| Year | Title | Cited |
|---|---|---|
| 2004 | A. (2004). Prasad, Manishi ; Shikiar, Rich ; Wahlqvist, Peter . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:4:p:225-244. Full description at Econpapers || Download paper | 421 |
| 2006 | Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment. (2006). Sculpher, Mark ; Philips, Zoe ; Golder, Su. In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:4:p:355-371. Full description at Econpapers || Download paper | 23 |
| 1998 | The Economics of Parallel Trade. (1998). . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:3:p:293-304. Full description at Econpapers || Download paper | 18 |
| 2001 | Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996). (2001). Mitchell, Andrew ; George, Bethan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:11:p:1103-1109. Full description at Econpapers || Download paper | 15 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A Users Guide. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 15 |
| 2012 | Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal. (2012). Epstein, David ; Woolacott, Nerys ; Sculpher, Mark ; Bojke, Laura ; Light, Kate ; Bruce, Ian N. ; Yang, Huiqin ; Craig, Dawn . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 14 |
| 2004 | A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries. (2004). Jager, Hans ; Feenstra, Talitha ; Welte, Robert . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:13:p:857-876. Full description at Econpapers || Download paper | 13 |
| 2003 | European Healthcare Policies for Controlling Drug Expenditure. (2003). Schneeweiss, Sebastian ; Szucs, Thomas D. ; Ess, Silvia M.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:2:p:89-103. Full description at Econpapers || Download paper | 11 |
| 2000 | Handling Uncertainty in Cost-Effectiveness Models. (2000). Briggs, Andrew H.. In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:479-500. Full description at Econpapers || Download paper | 11 |
| 2011 | Effects of Reference Pricing in Pharmaceutical Markets: A Review. (2011). Matteo Maria. Galizzi, ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 10 |
| 2006 | Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis. (2006). Ades, A. E. ; Cooper, Nicola ; Welton, Nicky ; Sculpher, Mark ; Abrams, Keith ; Lu, Guobing ; Sutton, Alex . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:1:p:1-19. Full description at Econpapers || Download paper | 9 |
| 2004 | Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall. (2004). Stolk, Elly A. ; Werner B. F. Brouwer, ; Jan J. V. Busschbach, ; Van Donselaar, Gijs . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:17:p:1097-1107. Full description at Econpapers || Download paper | 9 |
| 2008 | An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare. (2008). van den Berg, Bernard ; Werner B. F. Brouwer, ; N. Job A. van Exel, ; Koopmanschap, Marc A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:269-280. Full description at Econpapers || Download paper | 8 |
| 2005 | Pharmacoeconomic Analyses Using Discrete Event Simulation. (2005). Caro, Jaime J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:4:p:323-332. Full description at Econpapers || Download paper | 7 |
| 2000 | Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application. (2000). Fenwick, Elisabeth ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:461-477. Full description at Econpapers || Download paper | 7 |
| 2002 | Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life. (2002). Shmueli, Amir . In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:6:p:405-412. Full description at Econpapers || Download paper | 7 |
| 2011 | Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different. (2011). Menon, Devidas ; Stafinski, Tania ; Philippon, Donald J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:6:p:475-495. Full description at Econpapers || Download paper | 7 |
| 2000 | Testing the Validity of Cost-Effectiveness Models. (2000). Dixon, Simon . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:501-513. Full description at Econpapers || Download paper | 7 |
| 2012 | Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach. (2012). Lee, Henry ; Peasgood, Tessa ; Dolan, Paul . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers || Download paper | 7 |
| 2000 | Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio. (2000). O'Hagan, Anthony ; Stevens, John W. ; Montmartin, Jacques . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:4:p:339-349. Full description at Econpapers || Download paper | 7 |
| 2005 | The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project. (2005). de Pouvourville, Gerard ; Boulenger, Stephanie ; Drummond, Michael ; Glanville, Julie . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:2:p:113-120. Full description at Econpapers || Download paper | 6 |
| 2003 | Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies. (2003). Jonsson, Bengt ; Zethraeus, Niklas ; Lothgren, Mickael ; Tambour, Magnus . In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:1:p:39-48. Full description at Econpapers || Download paper | 6 |
| 2009 | Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected. (2009). Tsuchiya, Aki ; McCabe, Christopher ; Wailoo, Allan . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:12:p:983-989. Full description at Econpapers || Download paper | 5 |
| 2008 | Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe. (2008). Haycox, Alan ; Bertele, Vittorio ; Gustafsson, Lars L. ; Andersson, Karolina ; Godman, Brian ; Wettermark, Bjorn . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:7:p:537-550. Full description at Econpapers || Download paper | 5 |
| 2006 | Cost-of-Illness Studies: A Review of Current Methods. (2006). Mullins, Daniel C. ; Blatt, Lisa ; Ju, Jing ; Akobundu, Ebere . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:9:p:869-890. Full description at Econpapers || Download paper | 5 |
| 2008 | Use of Indirect and Mixed Treatment Comparisons for Technology Assessment. (2008). Ades, A. E. ; Cooper, Nicola ; Abrams, Keith ; Sutton, Alex . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:753-767. Full description at Econpapers || Download paper | 5 |
| 2010 | Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems. (2010). McCabe, Christopher J. ; Stafinski, Tania ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:113-142. Full description at Econpapers || Download paper | 5 |
| 2010 | Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. (2010). Puig-Junoy, Jaume . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663. Full description at Econpapers || Download paper | 5 |
| 2001 | Developing Guidance for Budget Impact Analysis. (2001). Hutton, John ; Trueman, Paul ; Drummond, Michael . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:6:p:609-621. Full description at Econpapers || Download paper | 5 |
| 2008 | The NICE Cost-Effectiveness Threshold: What it is and What that Means. (2008). . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:733-744. Full description at Econpapers || Download paper | 5 |
| 2002 | Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes. (2002). McNeil, John J. ; Ioannides-Demos, Lisa L. ; Ibrahim, Joseph E.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:9:p:577-591. Full description at Econpapers || Download paper | 5 |
| 2002 | Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis. (2002). Fendrick, Mark A. ; de Wit, Ardine G. ; Pechevis, Marc ; Edmunds, John W. ; Glick, Henry A. ; Ginsberg, Gary M. ; Antonanzas, Fernando ; Mast, Eric ; Eddy K. A. Van Doorslaer, ; Feilden, Rachel ; Evans, David ; Beutels, Philippe ; van Hout, Ben A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:1:p:1-7. Full description at Econpapers || Download paper | 5 |
| 2010 | Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products. (2010). Towse, Adrian ; Garrison, Louis P.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:93-102. Full description at Econpapers || Download paper | 5 |
| 2002 | Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma. (2002). Zillich, Alan J. ; Freeman, Patricia ; Blumenschein, Karen . In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:4:p:257-265. Full description at Econpapers || Download paper | 5 |
| 2010 | Access with Evidence Development Schemes: A Framework for Description and Evaluation. (2010). McCabe, Christopher J. ; Stafinski, Tania ; Edlin, Richard ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:143-152. Full description at Econpapers || Download paper | 4 |
| 2010 | Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal. (2010). Bagust, Adrian ; Dundar, Yenal ; Dickson, Rumona ; Shaw, Richard ; Fleeman, Nigel ; Greenhalgh, Janette ; McLeod, Claire ; Proudlove, Christine ; Boland, Angela . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:439-448. Full description at Econpapers || Download paper | 4 |
| 1999 | Willingness to Pay as a Measure of Health Benefits. (1999). Mauskopf, Josephine A. ; Bala, Mohan V. ; Wood, Lisa L.. In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:1:p:9-18. Full description at Econpapers || Download paper | 4 |
| 1999 | Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies. (1999). Revicki, Dennis A. ; Frank, Lori . In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:5:p:423-434. Full description at Econpapers || Download paper | 4 |
| 2008 | Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies. (2008). Haycox, Alan ; Schwabe, Ulrich ; Garattini, Silvio ; Joppi, Roberta ; Godman, Brian . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:2:p:91-98. Full description at Econpapers || Download paper | 4 |
| 1998 | An Introduction to Markov Modelling for Economic Evaluation. (1998). Briggs, Andrew ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:4:p:397-409. Full description at Econpapers || Download paper | 4 |
| 2001 | Accounting for Noncompliance in Pharmacoeconomic Evaluations. (2001). Bagust, Adrian ; Walley, Tom ; Hughes, Dyfrig A. ; Haycox, Alan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:12:p:1185-1197. Full description at Econpapers || Download paper | 4 |
| 2005 | Price Differentiation and Transparency in the Global Pharmaceutical Marketplace. (2005). . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:7:p:651-658. Full description at Econpapers || Download paper | 4 |
| 2007 | Conjoint Analysis of French and German Parents Willingness to Pay for Meningococcal Vaccine. (2007). Saleh, Aneta ; Brice, Roger ; Ehreth, Jenifer ; Girod, Isabelle . In: PharmacoEconomics. RePEc:wkh:phecon:v:25:y:2007:i:2:p:143-154. Full description at Econpapers || Download paper | 4 |
| 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7. (2012). Lichtenberg, Frank R.. In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:3:p:197-211. Full description at Econpapers || Download paper | 4 |
| 2006 | Hospitalisation Costs of Cystic Fibrosis. (2006). Staab, Doris ; Busse, Reinhard ; Bluemel, Miriam ; Schreyogg, Jonas ; Hollmeyer, Helge . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:10:p:999-1009. Full description at Econpapers || Download paper | 4 |
| 2008 | The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4. (2008). Mitchell, Andrew ; Scuffham, Paul A. ; Whitty, Jennifer A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:297-310. Full description at Econpapers || Download paper | 4 |
| 2010 | Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider. (2010). Flynn, Terry N.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:9:p:711-722. Full description at Econpapers || Download paper | 4 |
| 1999 | Determining Clinically Important Differences in Health Status Measures: A General Approach with Illustration to the Health Utilities Index Mark II. (1999). Edelman, David ; Williams, Rhys G. ; Rothman, Margaret L. ; Lipscomb, Joseph ; Samsa, Greg ; Matchar, David . In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:2:p:141-155. Full description at Econpapers || Download paper | 4 |
| 2012 | Common Drug Review Recommendations: An Evidence Base for Expectations?. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert B. ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:3:p:229-246. Full description at Econpapers || Download paper | 4 |
| 2010 | Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick J. ; Stockler, Martin R. ; Chim, Lesley . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:463-475. Full description at Econpapers || Download paper | 4 |
50 most relevant documents in this series:
Papers most cited in the last two years. [Click on heading to sort table]
| Year | Title | Cited |
|---|---|---|
| 2004 | A. (2004). Prasad, Manishi ; Shikiar, Rich ; Wahlqvist, Peter . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:4:p:225-244. Full description at Econpapers || Download paper | 42 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A Users Guide. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 13 |
| 2012 | Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal. (2012). Epstein, David ; Woolacott, Nerys ; Sculpher, Mark ; Bojke, Laura ; Light, Kate ; Bruce, Ian N. ; Yang, Huiqin ; Craig, Dawn . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 11 |
| 2006 | Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment. (2006). Sculpher, Mark ; Philips, Zoe ; Golder, Su. In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:4:p:355-371. Full description at Econpapers || Download paper | 8 |
| 2011 | Effects of Reference Pricing in Pharmaceutical Markets: A Review. (2011). Matteo Maria. Galizzi, ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 7 |
| 2012 | Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach. (2012). Lee, Henry ; Peasgood, Tessa ; Dolan, Paul . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers || Download paper | 7 |
| 2005 | The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project. (2005). de Pouvourville, Gerard ; Boulenger, Stephanie ; Drummond, Michael ; Glanville, Julie . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:2:p:113-120. Full description at Econpapers || Download paper | 6 |
| 2011 | Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different. (2011). Menon, Devidas ; Stafinski, Tania ; Philippon, Donald J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:6:p:475-495. Full description at Econpapers || Download paper | 6 |
| 2010 | Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems. (2010). McCabe, Christopher J. ; Stafinski, Tania ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:113-142. Full description at Econpapers || Download paper | 5 |
| 2003 | European Healthcare Policies for Controlling Drug Expenditure. (2003). Schneeweiss, Sebastian ; Szucs, Thomas D. ; Ess, Silvia M.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:2:p:89-103. Full description at Econpapers || Download paper | 5 |
| 2010 | Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products. (2010). Towse, Adrian ; Garrison, Louis P.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:93-102. Full description at Econpapers || Download paper | 4 |
| 2001 | Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996). (2001). Mitchell, Andrew ; George, Bethan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:11:p:1103-1109. Full description at Econpapers || Download paper | 4 |
| 2008 | The NICE Cost-Effectiveness Threshold: What it is and What that Means. (2008). . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:733-744. Full description at Econpapers || Download paper | 4 |
| 2008 | Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe. (2008). Haycox, Alan ; Bertele, Vittorio ; Gustafsson, Lars L. ; Andersson, Karolina ; Godman, Brian ; Wettermark, Bjorn . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:7:p:537-550. Full description at Econpapers || Download paper | 4 |
| 2008 | The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4. (2008). Mitchell, Andrew ; Scuffham, Paul A. ; Whitty, Jennifer A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:297-310. Full description at Econpapers || Download paper | 4 |
| 2010 | Access with Evidence Development Schemes: A Framework for Description and Evaluation. (2010). McCabe, Christopher J. ; Stafinski, Tania ; Edlin, Richard ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:143-152. Full description at Econpapers || Download paper | 4 |
| 2012 | Common Drug Review Recommendations: An Evidence Base for Expectations?. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert B. ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:3:p:229-246. Full description at Econpapers || Download paper | 4 |
| 2011 | Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders. (2011). Papenburg, Joc ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 3 |
| 2009 | Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected. (2009). Tsuchiya, Aki ; McCabe, Christopher ; Wailoo, Allan . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:12:p:983-989. Full description at Econpapers || Download paper | 3 |
| 2004 | A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries. (2004). Jager, Hans ; Feenstra, Talitha ; Welte, Robert . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:13:p:857-876. Full description at Econpapers || Download paper | 3 |
| 2010 | Is There a Role for Pharmacoeconomics in Developing Countries?. (2010). Babar Zaheer-Ud-Din, ; Scahill, Shane . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:12:p:1069-1074. Full description at Econpapers || Download paper | 3 |
| 2005 | Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda. (2005). Burdorf, Alex ; Meerding, Willem Jan ; Koopmanschap, Marc ; Jacob, Karin ; Severens, Hans . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:1:p:47-54. Full description at Econpapers || Download paper | 3 |
| 2010 | International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US. (2010). Levy, Adrian R. ; Johnston, Karissa M. ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew H.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:10:p:813-830. Full description at Econpapers || Download paper | 3 |
| 1998 | The Economics of Parallel Trade. (1998). . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:3:p:293-304. Full description at Econpapers || Download paper | 3 |
| 1998 | An Introduction to Markov Modelling for Economic Evaluation. (1998). Briggs, Andrew ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:4:p:397-409. Full description at Econpapers || Download paper | 3 |
| 2008 | An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare. (2008). van den Berg, Bernard ; Werner B. F. Brouwer, ; N. Job A. van Exel, ; Koopmanschap, Marc A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:269-280. Full description at Econpapers || Download paper | 3 |
| 2011 | Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence. (2011). Hulme, Claire ; Hall, Peter S. ; Round, Jeff ; Cameron, David A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:5:p:415-432. Full description at Econpapers || Download paper | 3 |
| 2000 | Testing the Validity of Cost-Effectiveness Models. (2000). Dixon, Simon . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:501-513. Full description at Econpapers || Download paper | 3 |
| 2008 | Use of Indirect and Mixed Treatment Comparisons for Technology Assessment. (2008). Ades, A. E. ; Cooper, Nicola ; Abrams, Keith ; Sutton, Alex . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:753-767. Full description at Econpapers || Download paper | 2 |
| 1998 | How to Calculate Indirect Costs in Economic Evaluations. (1998). Liljas, Bengt . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:1-part-1:p:1-7. Full description at Econpapers || Download paper | 2 |
| 2010 | Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider. (2010). Flynn, Terry N.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:9:p:711-722. Full description at Econpapers || Download paper | 2 |
| 2009 | Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster. (2009). Rusinak, Donna ; Lieu, Tracy A. ; Prosser, Lisa A. ; Kleinman, Ken ; Ortega-Sanchez, Ismael R. ; G. Thomas. Ray, . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:12:p:1005-1016. Full description at Econpapers || Download paper | 2 |
| 2009 | A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes. (2009). Baio, Gianluca ; Russo, Pierluigi . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:8:p:645-655. Full description at Econpapers || Download paper | 2 |
| 2010 | Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms. (2010). Vernon, John A. ; Golec, Joseph . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:615-628. Full description at Econpapers || Download paper | 2 |
| 2010 | Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature. (2010). Duhig, Amy ; Fleurence, Rachael ; Birt, Julie ; Naci, Huseyin . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:5:p:363-379. Full description at Econpapers || Download paper | 2 |
| 1999 | The Effect of Managed Care on Prescription Drug Costs and Benefits. (1999). Lyles, Alan ; Palumbo, Francis B.. In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:2:p:129-140. Full description at Econpapers || Download paper | 2 |
| 2004 | Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data. (2004). Lundin, Douglas ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:1:p:29-42. Full description at Econpapers || Download paper | 2 |
| 2010 | Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. (2010). Puig-Junoy, Jaume . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663. Full description at Econpapers || Download paper | 2 |
| 2006 | Hospitalisation Costs of Cystic Fibrosis. (2006). Staab, Doris ; Busse, Reinhard ; Bluemel, Miriam ; Schreyogg, Jonas ; Hollmeyer, Helge . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:10:p:999-1009. Full description at Econpapers || Download paper | 2 |
| 1998 | The Economic Burden of Migraine to Society. (1998). Ferrari, Michel D.. In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:6:p:667-676. Full description at Econpapers || Download paper | 2 |
| 1998 | Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults. (1998). Brown, Adalsteinn D. ; Garber, Alan M.. In: PharmacoEconomics. RePEc:wkh:phecon:v:14:y:1998:i:1:p:27-48. Full description at Econpapers || Download paper | 2 |
| 1999 | Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies. (1999). Revicki, Dennis A. ; Frank, Lori . In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:5:p:423-434. Full description at Econpapers || Download paper | 2 |
| 2007 | A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD. (2007). Hornby, Edward ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:25:y:2007:i:10:p:829-841. Full description at Econpapers || Download paper | 2 |
| 1998 | Does Managed Care Fuel Pharmaceutical Industry Growth?. (1998). Deardorff, Frank W. ; Murray, Michael D.. In: PharmacoEconomics. RePEc:wkh:phecon:v:14:y:1998:i:4:p:341-348. Full description at Econpapers || Download paper | 2 |
| 2001 | Accounting for Noncompliance in Pharmacoeconomic Evaluations. (2001). Bagust, Adrian ; Walley, Tom ; Hughes, Dyfrig A. ; Haycox, Alan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:12:p:1185-1197. Full description at Econpapers || Download paper | 2 |
| 2006 | Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?. (2006). Krol, Marieke ; Sendi, Pedram . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:4:p:401-414. Full description at Econpapers || Download paper | 2 |
| 2003 | Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies. (2003). Krauth, Christian ; Welte, Tobias ; Busse, Reinhard ; Jalilvand, Noushin . In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:14:p:1001-1024. Full description at Econpapers || Download paper | 2 |
| 2005 | Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK. (2005). Secnik, Kristina ; Mannix, Sally ; Sallee, Randy F. ; Matza, Louis S.. In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:8:p:777-790. Full description at Econpapers || Download paper | 2 |
| 2008 | Valuing Health States for Use in Cost-Effectiveness Analysis. (2008). Brazier, John . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:769-779. Full description at Econpapers || Download paper | 2 |
| 2006 | Economic Evaluations in the Canadian Common Drug Review. (2006). Laupacis, Andreas . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:11:p:1157-1162. Full description at Econpapers || Download paper | 2 |
Citing documents used to compute impact factor 8:
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2014 | Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries. (2014). Rencz, Fanni ; Brodszky, Valentin ; Lopert, Ruth ; Baji, Petra ; Hever, Noemi ; Pentek, Marta ; Gulacsi, Laszlo . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:1:p:27-34. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. (2014). Fernandez, Jose-Luis ; Knapp, Martin ; Cerri, Karin . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:7:p:681-695. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Analysing coverage decision-making: opening Pandoraâs box?. (2014). Fischer, Katharina . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:9:p:899-906. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Access to innovation: Is there a difference in the use of expensive anticancer drugs between French hospitals?. (2014). Van der Laan, Chantal ; Delibes, Michel ; Chevalier, Julie ; Bonastre, Julia ; de Pouvourville, Gerard . In: Health Policy. RePEc:eee:hepoli:v:116:y:2014:i:2:p:162-169. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999â2010. (2014). Lichtenberg, Frank R. ; alkan, Zafer ; Tatar, Mehtap . In: Health Policy. RePEc:eee:hepoli:v:117:y:2014:i:3:p:361-373. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices. (2014). van de Vooren, Katelijne ; Ghislandi, Simone ; Duranti, Silvy ; Curto, Sandro ; Garattini, Livio . In: Health Policy. RePEc:eee:hepoli:v:116:y:2014:i:2:p:182-187. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Krol, Marieke ; Brouwer, Werner . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres. (2014). Szegedi, Andrea ; Brodszky, Valentin ; Karpati, Sarolta ; Baji, Petra ; Hollo, Peter ; Balogh, Orsolya ; Gulacsi, Laszlo ; Herszenyi, Krisztina ; Jokai, Hajnalka ; Remenyik, eva ; Heredi, Emese . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:1:p:101-109. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2012
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2012 | Counterfeit or Substandard? Assessing Price and Non-Price Signals of Drug Quality. (2012). Mathur, Aparna ; Bate, Roger ; Jin, Ginger Zhe . In: NBER Working Papers. RePEc:nbr:nberwo:18073. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009. (2012). Lichtenberg, Frank R.. In: NBER Working Papers. RePEc:nbr:nberwo:18235. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files. (2012). . In: NBER Working Papers. RePEc:nbr:nberwo:18552. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | The Authorsâ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6â11 Years. (2012). McKenna, Claire ; Griffin, Susan ; Walker, Simon ; Woolacott, Nerys ; Wright, Kath ; Burch, Jane ; Paton, James . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:991-1004. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Bevacizumab for Metastatic Colorectal Cancer. (2012). Pandor, Abdullah ; Whyte, Sophie ; Stevenson, Matt . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1119-1132. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura. (2012). Jenkinson, David ; Jia, Xueli ; Mowatt, Graham ; Boyers, Dwayne . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:6:p:483-495. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2011
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2011 | Competition and the Reference Pricing Scheme for pharmaceuticals. (2011). Ghislandi, Simone . In: Journal of Health Economics. RePEc:eee:jhecon:v:30:y:2011:i:6:p:1137-1149. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2011 | Valuing qalys at the end of life. (2011). Corbacho, Belen ; Jose Luis Pinto Prades, ; PintoPrades, Jose Luis ; Martinez, Fernando Sanchez . In: Working Papers. RePEc:pab:wpaper:11.15. Full description at Econpapers || Download paper | [Citation Analysis] |
10 most frequent citing series:
[Click on heading to sort table]
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.